{"id":13918,"date":"2021-02-16T07:31:58","date_gmt":"2021-02-16T07:31:58","guid":{"rendered":"https:\/\/clinlabint.com\/?p=13918"},"modified":"2021-02-16T07:31:58","modified_gmt":"2021-02-16T07:31:58","slug":"sekisui-diagnostics-launches-osom-ultra-plus-flu-ab-test","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/sekisui-diagnostics-launches-osom-ultra-plus-flu-ab-test\/","title":{"rendered":"SEKISUI Diagnostics launches OSOM Ultra Plus Flu A&B Test"},"content":{"rendered":"

\"SEKISUI<\/p>\n

SEKISUI Diagnostics\u00a0<\/strong>has launched the\u00a0OSOM Ultra Plus Flu A&B Test.\u00a0<\/strong>The test\u00a0utilizes traditional lateral flow technology with performance near or exceeding sensitivity of other reader-based tests without using an instrument.\u00a0It is intended for the qualitative detection of influenza type A and type B nucleoprotein antigens directly from nasal or nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection.<\/p>\n

 <\/p>\n

High performance, point-of-care rapid test for the detection of Influenza A&B<\/strong><\/p>\n